| Bethesda
Conference 24
Cardiac
Transplantation
November 5-5, 1992
Published: Vol 22, No 1, Jul 93:1-64 Journal of the
American College of Cardiology
Over the past decade, heart transplantation has evolved
from a rarely performed experimental procedure to an
accepted therapy for end-stage heart disease. The understanding
of the immune response at increasingly fundamental levels
combined with information from in vivo models of organ
transplantation have enabled rapid advances in the development
of new immunosuppressive modalities. This Conference
report addresses both future developments in immunosuppression
which may help optimize the use of scarce cardiac allografts,
and the potential alternatives to allotransplantation
which may minimize, if not obviate, the need for human
donor hearts.
Copyright
© 2000 American College of Cardiology
|